October 12, 2017 (HealthDay News) Patients with severe neurotoxicity after infusion of CD19-targeted chimeric antigen receptor-modified T (CAR-T) cells have evidence of endothelial activation, according to a study published online …
Neurotoxicity Characterized After Infusion of CD19 CAR-T Cells Read More
Published on February 13, 2018 Sattva S. Neelapu, MD, discusses the safety and practical implications for axi-cel (KTE-C19) as part of the ZUMA-1 trial, as well as the future for …
Axi-Cel and Future of CAR T-Cell Therapy in Lymphoma Read More
Diagnosed with lymphoma, Nick Howe was out of options before he tried CAR T-Cell therapy at Nebraska Medicine. Today, the Omaha firefighter is in remission and expecting his first baby. …
Omaha Firefighter Receives CAR T-Cell Therapy – Nebraska Medicine Read More
January 31, 2018 (HealthDay News) Single infusion provided durable remission with long-term persistence in pediatric, young adult patients A single infusion of the anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, …
Tisagenlecleucel Beneficial for Youth With Refractory B-Cell ALL Read More
Here are some links to studies that have recently come out on CAR T-Cell. These are obtainable only by a paid subscription to the journal. March 2018 Apoptotic Cells Dramatically …
Other Studies on CAR T-Cell Therapy Read More